Impact of eligibility for diabetes remission on response to intensive lifestyle intervention in overweight and obese people with type 2 diabetes: The Look AHEAD trial
Diabetes, Obesity and Metabolism · 2025
DOI: 10.1111/dom.16650 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Joanna Y Gong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Diabetes and Epidemiology, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Obesity, Overweight. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Health and Medical Research Council Investigator Grants, National Institutes of Health.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
To achieve remission of type 2 diabetes, resources to support intensive lifestyle intervention (ILI) are directed toward people with diabetes for whom remission is achievable, that is, people with short diabetes duration and lower HbA1c. We aimed to determine if responses to ILI, other than remission, justify this resource allocation. Materials and Methods We analysed participants from the Look AHEAD randomised controlled trial who were 20–65 years old with a BMI of 27–45 kg/m 2 . The effect of ILI was assessed after stratification for remission eligibility at baseline (diabetes duration ≤6 years and no insulin therapy). Cox proportional hazards models evaluated the effect of ILI on incident CVD, chronic kidney disease (CKD), and mortality. Linear models with generalised least squares assessed the effect of ILI on weight, HbA1c, systolic blood pressure, LDL, and eGFR.
Results
There were 3105 participants included—60% women, median age 58 years, and median follow‐up time 9 years (IQR 8–10 years). At baseline, 54% were eligible for remission. Remission eligibility status did not modify the effect of ILI on CVD, CKD, or mortality. ILI led to 2.4 kg greater weight loss (−5.53 kg (95% CI −6.02, −5.03) vs. −3.17 kg (95% CI −3.86, −2.49)), and 0.1% greater HbA1c reduction (−0.28% (95% CI −0.33, −0.23) vs. −0.17% (95% CI −0.23, −0.11)) in eligible compared with ineligible people.
Conclusions
The small additional benefit of ILI in people eligible for remission, compared with ineligible people, may not be enough to justify restricting resources for ILI to such eligible people.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Diabetes and Epidemiology, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
- Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
- Department of Endocrinology and Diabetes, Western Health, Melbourne, Victoria, Australia.
- School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.
- Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.
- School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
ORCID-Profile: Joanna Y Gong, Agus Salim, Dianna J Magliano, Jonathan E Shaw
Förderung
- NIH HHS
- National Health and Medical Research Council Investigator Grants
- National Institutes of Health
Zitieren
APA
Gong, J. Y., Salim, A., Magliano, D. J., & Shaw, J. E. (2025). Impact of eligibility for diabetes remission on response to intensive lifestyle intervention in overweight and obese people with type 2 diabetes: The Look AHEAD trial. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16650
Vancouver
Gong JY, Salim A, Magliano DJ, Shaw JE. Impact of eligibility for diabetes remission on response to intensive lifestyle intervention in overweight and obese people with type 2 diabetes: The Look AHEAD trial. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16650
BibTeX
@article{Gong2025,
author = {Gong, Joanna Y and Salim, Agus and Magliano, Dianna J and Shaw, Jonathan E},
title = {Impact of eligibility for diabetes remission on response to intensive lifestyle intervention in overweight and obese people with type 2 diabetes: The Look AHEAD trial},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
doi = {10.1111/dom.16650}
}
EUVIMED